CYTK logo

Cytokinetics, Incorporated (CYTK)

Profile

Full Name

Cytokinetics, Incorporated

Ticker

NASDAQ: CYTK

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

April 30, 2004

Indexes

Not included

Website

https://www.cytokinetics.com

Employees

498

Key Details

Price

$36.69(-2.52%)

Market cap

$4.38B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$18.47M(+145.34% YoY)

Annual EPS

-$5.26(+3.49% YoY)

PE ratio

-

Next earnings date

Aug 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $36.69
    CYTK price is $36.69

    30-Day Relative Volume

    0.76
    CYTK 30-day relative volume is 0.76

    Price Performance

    Price Most recent change

    -2.52%
    CYTK price was down -2.52% on Aug 1, 2025

    Price YTD change

    -22%
    CYTK price is down -22% since January 1st

    Price 1-year change

    -36.64%
    CYTK price is down -36.64% year-on-year

    Price 3-year change

    -10.75%
    CYTK price is down -10.75% over the past 3 years

    Price Range

    Price All-time high

    $110.25
    CYTK price is currently -66.72% below its historical high of $110.25

    Price 3-year low

    $25.98
    CYTK price is currently +41.22% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $4.38B
    CYTK market capitalization is $4.38 billion

    Market cap 3-year change

    +24.06%
    CYTK market capitalization is up +24.06% over the past 3 years

    Market cap All-time high

    $11.42B
    CYTK market capitalization is currently -61.62% below its historical high of $11.42 billion

    Market cap sector rank

    88.12%
    CYTK market capitalization is higher than 88.12% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +1.62%
    CYTK shares outstanding is up +1.62% year-on-year

    Shares Outstanding 3-Year Change

    +39.01%
    CYTK shares outstanding is up +39.01% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.79
    CYTK beta is 0.79

    200-day SMA

    $42.95
    CYTK price is currently -14.58% below its 200-day simple moving average

    50-day SMA

    $34.33
    CYTK price is currently +6.87% above its 50-day simple moving average

    RSI

    52.61
    CYTK 14-day relative strength index is 52.61

    Volume

    0.76
    CYTK 30-day relative volume is 0.76

    ATR

    $1.55
    CYTK average true range is $1.55

    10-day Historical Volatility

    32.17%
    CYTK 10-day historical volatility is 32.17%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $18.47M
    CYTK annual revenue is $18.47 million

    Revenue Analysts estimate

    $22.66M
    CYTK annual revenue is currently -18.46% lower than the consensus analysts' forecast

    Revenue 1-year change

    +145.34%
    CYTK annual revenue is up +145.34% year-on-year

    Revenue Sector rank

    33.3%
    CYTK annual revenue is higher than 33.3% of companies in Healthcare sector

    EPS

    EPS

    -$5.26
    CYTK annual earnings per share is -$5.26

    EPS Analysts estimate

    -$5.53
    CYTK annual earnings per share is currently -4.97% lower than the consensus analysts' forecast

    EPS 1-year change

    +3.49%
    CYTK annual earnings per share is up +3.49% year-on-year

    EPS Sector rank

    19.97%
    CYTK annual earnings per share is higher than 19.97% of companies in Healthcare sector

    Profit

    Gross profit

    -$320.93M
    CYTK annual gross profit is -$320.93 million

    Gross margin

    -1737.22%
    CYTK annual gross profit margin is -1737.22%

    Operating profit

    -$536.25M
    CYTK annual operating income is -$536.25 million

    Operating margin

    -2902.72%
    CYTK annual operating profit margin is -2902.72%

    Net income

    -$589.53M
    CYTK annual net profit is -$589.53 million

    Net margin

    -3191.11%
    CYTK annual net profit margin is -3191.11%

    Expenses

    Total expenses

    $554.72M
    CYTK annual total expenses is $554.72 million

    Operating expenses

    $215.31M
    CYTK annual total operating expenses is $215.31 million

    Cost of goods sold

    $339.41M
    CYTK annual cost of goods sold is $339.41 million

    Selling, general & administrative expenses

    $215.31M
    CYTK annual SGA is $215.31 million

    Depreciation and amortization

    $9.53M
    CYTK annual depreciation & amortization is $9.53 million

    Interest expense

    $86.51M
    CYTK annual interest expense is $86.51 million

    Income tax

    -
    CYTK annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$503.01M
    CYTK annual earnings before interest & taxes is -$503.01 million

    EBITDA

    -$493.48M
    CYTK annual EBITDA is -$493.48 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $1.40B
    CYTK annual total assets is $1.40 billion

    Non current assets

    $293.73M
    CYTK annual long term assets is $293.73 million

    Current assets

    $1.11B
    CYTK annual total current assets is $1.11 billion

    Cash and cash equivalents

    $94.86M
    CYTK annual cash & cash equivalents is $94.86 million

    Accounts receivable

    $16.65M
    CYTK annual accounts receivable is $16.65 million

    Inventory

    -
    CYTK annual inventory value is unknown

    Liabilities

    Total liabilities

    $1.54B
    CYTK annual total liabilities is $1.54 billion

    Long term liabilities

    $1.36B
    CYTK annual total long term liabilities is $1.36 billion

    Current liabilities

    $179.67M
    CYTK annual total current liabilities is $179.67 million

    Accounts payable

    $20.37M
    CYTK annual accounts payable is $20.37 million

    Debt

    Total debt

    $788.68M
    CYTK annual total debt is $788.68 million

    Total debt 1-year change

    +4.35%
    CYTK annual total debt is up +4.35% year-on-year

    Long term debt

    $758.18M
    CYTK annual long term debt is $758.18 million

    Short term debt

    $30.50M
    CYTK annual short term debt is $30.50 million

    Equity & Capital

    Shareholders equity

    -$135.37M
    CYTK annual stockholders equity is -$135.37 million

    Book value

    -$135.37M
    CYTK annual book value is -$135.37 million

    Retained earnings

    -$2.70B
    CYTK annual retained earnings is -$2.70 billion

    Working capital

    $928.27M
    CYTK annual working capital is $928.27 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$395.89M
    CYTK annual cash flow from operations is -$395.89 million

    Cash from operations 1-year change

    +4.45%
    CYTK annual cash flow from operations is up +4.45% year-on-year

    Cash from investing

    -$553.10M
    CYTK annual cash flow from investing activities is -$553.10 million

    Cash from investing 1-year change

    -331.18%
    CYTK annual cash flow from investing activities is down -331.18% year-on-year

    Cash from financing

    $930.61M
    CYTK annual cash flow from financing activities is $930.61 million

    Cash from financing 1-year change

    +320.49%
    CYTK annual cash flow from financing activities is up +320.49% year-on-year

    CAPEX

    CAPEX

    $3.91M
    CYTK annual capital expenditures is $3.91 million

    CAPEX 1-year change

    +175.85%
    CYTK annual capital expenditures is up +175.85% year-on-year

    Free Cash Flow

    Free cash flow

    -$399.80M
    CYTK annual free cash flow is -$399.80 million

    Free cash flow 1-year change

    +3.84%
    CYTK annual free cash flow is up +3.84% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -1737.22%
    CYTK annual gross profit margin is -1737.22%

    Operating margin

    -2902.72%
    CYTK annual operating profit margin is -2902.72%

    Net margin

    -3191.11%
    CYTK annual net profit margin is -3191.11%

    ROA & ROE

    ROA

    -52.97%
    CYTK annual return on assets is -52.97%

    ROE

    435.49%
    CYTK annual return on equity is 435.49%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    CYTK price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    CYTK price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -16.45
    CYTK price to book ratio is -16.45

    PB ratio Sector rank

    2.99%
    CYTK price to book ratio is higher than 2.99% of companies in Healthcare sector

    PS Ratio

    PS ratio

    228.00
    CYTK price to sales ratio is 228.00

    PS ratio Sector rank

    96.54%
    CYTK price to sales ratio is higher than 96.54% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $5.10B
    CYTK enterprise value is $5.10 billion

    Enterprise value Sector rank

    88.54%
    CYTK enterprise value is higher than 88.54% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -9.93
    CYTK EV/EBITDA is -9.93

    EV/EBITDA Sector rank

    13.87%
    CYTK EV/EBITDA is higher than 13.87% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    6.17
    CYTK annual current ratio is 6.17

    Quick ratio

    -
    CYTK annual quick ratio value is unknown

    Leverage

    Debt to equity

    -4.85
    CYTK annual debt to equity ratio is -4.85

    Interest coverage ratio

    -5.81
    CYTK annual interest coverage ratio is -5.81

    Risk & Stability

    Piotroski F-Score

    3
    CYTK piotroski f-score is 3

    Altman Z-Score

    -1.36
    CYTK altman z-score is -1.36

    Analyst ratings

    Recent major analysts updates

    Jun 9, 25 JP Morgan
    Overweight
    May 29, 25 Mizuho
    Outperform
    May 14, 25 Needham
    Buy
    May 8, 25 Barclays
    Overweight
    May 7, 25 RBC Capital
    Outperform
    May 7, 25 Citigroup
    Buy
    May 2, 25 UBS
    Neutral
    May 2, 25 Needham
    Buy
    Apr 24, 25 Barclays
    Overweight
    Apr 21, 25 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with CYTK included

    Growing Shares Outstanding
    Mid cap stocks
    US stocks
    Stocks below SMA 200
    Most recommended stocks
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Cytokinetics, Incorporated?
    • Does Cytokinetics, Incorporated pay dividends?
    • What sector is Cytokinetics, Incorporated in?
    • What industry is Cytokinetics, Incorporated in?
    • What country is Cytokinetics, Incorporated based in?
    • When did Cytokinetics, Incorporated go public?
    • Is Cytokinetics, Incorporated in the S&P 500?
    • Is Cytokinetics, Incorporated in the NASDAQ 100?
    • Is Cytokinetics, Incorporated in the Dow Jones?
    • When was Cytokinetics, Incorporated's last earnings report?
    • When does Cytokinetics, Incorporated report earnings?

    What is the ticker symbol for Cytokinetics, Incorporated?

    The ticker symbol for Cytokinetics, Incorporated is NASDAQ:CYTK

    Does Cytokinetics, Incorporated pay dividends?

    No, Cytokinetics, Incorporated does not pay dividends

    What sector is Cytokinetics, Incorporated in?

    Cytokinetics, Incorporated is in the Healthcare sector

    What industry is Cytokinetics, Incorporated in?

    Cytokinetics, Incorporated is in the Biotechnology industry

    What country is Cytokinetics, Incorporated based in?

    Cytokinetics, Incorporated is headquartered in United States

    When did Cytokinetics, Incorporated go public?

    Cytokinetics, Incorporated's initial public offering (IPO) was on April 30, 2004

    Is Cytokinetics, Incorporated in the S&P 500?

    No, Cytokinetics, Incorporated is not included in the S&P 500 index

    Is Cytokinetics, Incorporated in the NASDAQ 100?

    No, Cytokinetics, Incorporated is not included in the NASDAQ 100 index

    Is Cytokinetics, Incorporated in the Dow Jones?

    No, Cytokinetics, Incorporated is not included in the Dow Jones index

    When was Cytokinetics, Incorporated's last earnings report?

    Cytokinetics, Incorporated's most recent earnings report was on May 12, 2025

    When does Cytokinetics, Incorporated report earnings?

    The next expected earnings date for Cytokinetics, Incorporated is August 7, 2025
    On this page